ALASTIN Skincare® Gets 2nd U.S. Patent for TriHex Technology
ALASTIN Skincare®, Inc. – a speciality aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, has announced Issuance of a 2nd U.S. Patent covering a variety of topical compositions based on ALASTIN’s TriHex Technology®. The novel technology is featured in both procedure-enhancement and daily skincare products.
ALASTIN’s Procedure Enhancement line of products supports the body’s natural healing processes related to the generation of new collagen and elastin after a procedure. Key products in the line include ALASTIN’s Regenerating Skin Nectar with TriHex Technology® and the recently launched breakthrough product TransFORM Body Treatment with TriHex Technology®.
According to Dr Alan Widgerow – Chief Medical Officer at ALASTIN, “Finding the right combination of ingredients that work synergistically to deliver meaningful results is a challenge. We are thrilled to have developed the perfect combination with our TriHex Technology®. We are constantly seeking new breakthroughs in the combined actions of specifically selected peptides and other ingredients that address unmet needs in the aesthetic arena.”
“The ALASTIN portfolio is built from innovation, supported by clinical rigor and our patented TriHex Technology®; all of which continue to be a cornerstone of our success,” commented Diane S. Goostree, CEO of ALASTIN Skincare.